It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Survivin’s dual function as apoptosis inhibitor and regulator of cell proliferation is mediated via its interaction with the export receptor CRM1. This protein–protein interaction represents an attractive target in cancer research and therapy. Here, we report a sophisticated strategy addressing Survivin’s nuclear export signal (NES), the binding site of CRM1, with advanced supramolecular tweezers for lysine and arginine. These were covalently connected to small peptides resembling the natural, self-complementary dimer interface which largely overlaps with the NES. Several biochemical methods demonstrated sequence-selective NES recognition and interference with the critical receptor interaction. These data were strongly supported by molecular dynamics simulations and multiscale computational studies. Rational design of lysine tweezers equipped with a peptidic recognition element thus allowed to address a previously unapproachable protein surface area. As an experimental proof-of-principle for specific transport signal interference, this concept should be transferable to any protein epitope with a flanking well-accessible lysine.
Survivin’s dual function as apoptosis inhibitor and regulator of cell proliferation is mediated via its interaction with the export receptor CRM1. Here authors report a strategy addressing its dimer interface overlapping with the nuclear export signal, the binding site of CRM1, with advanced supramolecular tweezers for lysine and arginine.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details









1 University of Duisburg-Essen, Department of Molecular Biology II, Centre for Medical Biotechnology (ZMB), Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445)
2 University of Duisburg-Essen, Institute of Organic Chemistry I, Faculty of Chemistry, Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445)
3 University of Duisburg-Essen, Department of Structural and Medicinal Biology, Centre for Medical Biotechnology (ZMB), Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445)
4 University of Duisburg-Essen, Department of Computational Biochemistry, Centre for Medical Biotechnology (ZMB), Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445)
5 University of Duisburg-Essen, Department of Bioinformatics and Computational Biophysics, Centre for Medical Biotechnology (ZMB), Essen, Germany (GRID:grid.5718.b) (ISNI:0000 0001 2187 5445)